Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank14
3Y CAGR-38.1%
5Y CAGR-25.0%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-38.1%/yr
vs -3.1%/yr prior
5Y CAGR
-25.0%/yr
Recent deceleration
Acceleration
-34.9pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
20250.19-73.9%
20240.72-16.9%
20230.86+9.5%
20220.79+391.3%
2021-0.27-134.4%
20200.79+0.2%
20190.79-12.3%
20180.90-